3M and MIT Working on Rapid COVID-19 Diagnostic Test

Industrial giant 3M (NYSE: MMM) is working with researchers from MIT to develop a rapid-response COVID-19 test. The test was selected by the National Institutes of Health (NIH) to be included in a program to accelerate COVID-19 diagnostic initiatives. The NIH's Rapid Acceleration of Diagnostics Tech (RADx Tech) program will support a month-long process to verify that test meets the necessary standards and demonstrate that it can be produced on a large scale.